+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Drug Reference Apps Market Size, Share and Growth Outlook, 2026: Analysis By Platform (iOS , Android, Web-based), By Pricing Model (Free, Subscription-based, Freemium), By Application (Drug Information & Interaction Checking, Clinical Decision Support , Medical Dosage Calculation, Patient Education and Adherence), By End-User (Healthcare Professionals , Medical Students, Hospitals & Clinical Settings, Individual Patients) Companies, and Country Forecast, 2021 to 2034

Global Drug Reference Apps Market size is forecast to increase from $1.72 Billion in 2026 to $3.5 Billion in 2034 at a CAGR of 9.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006927
Pages: 223 Pages

Drug Eluting Stent (DES) Market Size, Share and Growth Outlook, 2026: Analysis By Coating Type (Durable Polymer-based DES, Bioresorbable Polymer-based DES, Polymer-free DES), By Stent Material (Cobalt-Chromium Alloy, Platinum-Chromium Alloy, Stainless Steel, Nitinol), By Generation (First-Generation, Second-Generation, Third-Generation, Fourth-Generation), By Application (Acute Coronary Syndrome, Stable Angina, Complex Lesions ), By End-User (Hospitals, Specialized Cardiac Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Drug Eluting Stent (DES) Market size is forecast to increase from $4.92 Billion in 2026 to $8.52 Billion in 2034 at a CAGR of 7.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006926
Pages: 219 Pages

Drug Eluting Cardiovascular Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Drug-Eluting Stents , Drug-Coated Balloons , Drug-Eluting Peripheral Stents, Drug-Eluting Bioresorbable Scaffolds ), By Drug Type (Sirolimus and Derivatives , Paclitaxel, Others ), By Application (Coronary Artery Disease , Peripheral Artery Disease ), By End-User (Hospitals, Cardiac Catheterization Centers, Ambulatory Surgical Centers , Specialty Heart Institutes) Companies, and Country Forecast, 2021 to 2034

Global Drug Eluting Cardiovascular Devices Market size is forecast to increase from $5.11 Billion in 2026 to $8.52 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006925
Pages: 223 Pages

Drug Eluting Balloons Market Size, Share and Growth Outlook, 2026: Analysis By Product (Coronary Drug-Eluting Balloon, Peripheral Drug-Eluting Balloon, Other Products ), By Drug Type (Paclitaxel-based Balloons, Sirolimus-based Balloons, Dual-drug ), By Coating Technology (FreePac, TransPac, EnduraCoat, Other Technologies), By Lesion Type (In-stent Restenosis, De-novo Small Vessel Disease, Femoropopliteal Lesions, Below-the-knee Lesions), By End User (Hospitals, Ambulatory Surgical Centers , Other End Users) Companies, and Country Forecast, 2021 to 2034

Global Drug Eluting Balloons Market size is forecast to increase from $890.44 Million in 2026 to $1660.39 Million in 2034 at a CAGR of 8.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006924
Pages: 219 Pages

Drug Discovery Outsourcing Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Medicinal Chemistry Services, Biology Services, DMPK , Hit-to-Lead & Lead Optimization, High-Throughput Screening ), By Drug Type (Small Molecules, Large Molecules, Cell & Gene Therapies, Peptide, RNA-based Therapeutics), By Therapeutic Area (Oncology, Infectious Disease, CNS & Neurology, Cardiovascular, Respiratory, Gastrointestinal, Autoimmune & Inflammatory, Metabolic Disorders), By Sourcing Model (Full-Time Equivalent , Fee-for-Service , Functional Service Partnership, Hybrid), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Drug Discovery Outsourcing Market size is forecast to increase from $9.9 Billion in 2026 to $23.48 Billion in 2034 at a CAGR of 11.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006923
Pages: 224 Pages

Drug Discovery Market Size, Share and Growth Outlook, 2026: Analysis By Type (Pharmacogenomics, High-Throughput Screening , Genomics, Bioinformatics, Biochips, Nanotechnology), By Drug Type (Small Molecule, Large Molecule ), By Therapeutic Area (Oncology, Neurology, Infectious & Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Drug Discovery Market size is forecast to increase from $17.53 Billion in 2026 to $38.68 Billion in 2034 at a CAGR of 10.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006922
Pages: 225 Pages

Drug Discovery Informatics Market Size, Share and Growth Outlook, 2026: Analysis By Workflow (Discovery Informatics , Development Informatics ), By Solution (Software Platforms , Professional & Managed Services), By Function (Sequencing & Target Data Analysis , Molecular Modeling & Simulation, Docking & Virtual Screening, Chemical Library & Database Preparation, ADME-Tox ), By Deployment Modality (Cloud-Based Systems, On-Premise ), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations , Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Drug Discovery Informatics Market size is forecast to increase from $4.37 Billion in 2026 to $11.05 Billion in 2034 at a CAGR of 12.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006921
Pages: 225 Pages

Drug Discovery and Development Laboratory Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Central Laboratory Services, Bioanalytical Services & ADME, Genomics , Biomarker Analysis & Discovery, Immunoassays & Flow Cytometry, Anatomic Pathology & Precision Medicine Assays, Toxicity ), By Drug Type (Small Molecule Drugs, Biologics & Biosimilars, Cell and Gene Therapies), By Development Phase (Discovery & Early-Stage Research Services, Preclinical Development Services, Clinical Trial Laboratory Services ), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations , Academic & Research Institutions) Companies, and Country Forecast, 2021 to 2034

Global Drug Discovery and Development Laboratory Services Market size is forecast to increase from $20.91 Billion in 2026 to $49.59 Billion in 2034 at a CAGR of 11.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006920
Pages: 222 Pages

Drug Device Combination Products Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Injectable Drug Delivery Device, Drug-Eluting Stents, Inhalers & Nebulizers, Transdermal Patches , Infusion Pumps, Drug-Eluting Balloon Catheters, Antimicrobial Wound Dressings), By Application (Diabetes Management, Cardiovascular Diseases, Respiratory Diseases , Oncology , Autoimmune & Inflammatory Diseases, Pain Management, Ophthalmology), By End-User (Hospitals & Clinics, Home Care Settings, Ambulatory Surgical Centers , Long-Term Care Facilities) Companies, and Country Forecast, 2021 to 2034

Global Drug Device Combination Products Market size is forecast to increase from $168.47 Million in 2026 to $333.23 Million in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006919
Pages: 221 Pages

Drug Delivery Devices Market Size, Share and Growth Outlook, 2026: Analysis By Route of Administration (Oral Drug Delivery, Parenteral Drug Delivery, Inhalation Drug Delivery, Transdermal Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery), By Device Type (Conventional Devices, Advanced), By Application (Oncology, Diabetes Management, Respiratory Diseases , Cardiovascular Diseases, Infectious Diseases, Autoimmune Disorders), By End-User (Hospitals and Diagnostic Centers, Ambulatory Surgical Centers, Home Care Settings, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Drug Delivery Devices Market size is forecast to increase from $495.01 Million in 2026 to $909.46 Million in 2034 at a CAGR of 7.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006918
Pages: 224 Pages